These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24495253)

  • 41. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades.
    Klaas M; Mäemets-Allas K; Heinmäe E; Lagus H; Arak T; Eller M; Kingo K; Kankuri E; Jaks V
    Cell Mol Life Sci; 2022 Feb; 79(3):157. PubMed ID: 35218417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
    Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
    J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma.
    Hu K; Zhong G; He F
    Int J Gynecol Cancer; 2005; 15(3):537-41. PubMed ID: 15882182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.
    Chen X; Yan Q; Li S; Zhou L; Yang H; Yang Y; Liu X; Wan X
    Cancer Lett; 2012 Jan; 314(1):41-53. PubMed ID: 21983130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
    Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S
    Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
    Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
    Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.
    Panoulis K; Christantoni E; Pliatsika P; Anagnostis P; Goulis DG; Kondi-Pafiti A; Armeni E; Augoulea A; Triantafyllou N; Creatsa M; Lambrinoudaki I
    Gynecol Endocrinol; 2015; 31(8):613-7. PubMed ID: 26036714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
    Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
    Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
    Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
    Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.